Emcure Pharma shares decline equity worth ₹574 crore changes hands in block deals

On Thursday, July 4, CNBC-TV18 reported, citing sources that Bain Capital-backed BC Investments IV was looking at selling 2.4% stake in the Emcure Pharma for ₹551 crore.

Leave a Reply

Your email address will not be published. Required fields are marked *